Gail Boudreaux, President and CEO of Elevance Health ($ELV), made three open market purchases totaling $2.4 million in the past year. Her most recent buy occurred on July 18, 2025. These purchases rank her 274th among nearly 5,000 insiders, above the average buy of $1.5 million across 3.3 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | TARGET CORP | $TGT | BOUDREAUX GAIL | Director | A | Common Stock | 2682 | $0.00 | 12,192.0000 | 455,700,000 | 28.20% | 0.00% |
| March 2, 2026 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 10527 | $0.00 | 171,047.0000 | 224,600,000 | 6.56% | 0.00% |
| March 2, 2026 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 16153 | $0.00 | 160,520.0000 | 224,600,000 | 11.19% | 0.01% |
| March 2, 2026 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | F | Common Stock | 6713 | $294.07 | 144,367.0000 | 224,600,000 | 4.44% | 0.00% |
| March 2, 2026 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 63818 | $0.00 | 63,818.0000 | 224,600,000 | 9999.99% | 0.03% |
| March 3, 2026 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | F | Common Stock | 1736 | $284.03 | 169,311.0000 | 224,600,000 | 1.01% | 0.00% |
| July 18, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | P | Common Stock | 2334 | $286.07 | 144,914.0000 | 232,900,000 | 1.64% | 0.00% |
| July 18, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | P | Common Stock | 5116 | $287.12 | 150,030.0000 | 232,900,000 | 3.53% | 0.00% |
| July 18, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | P | Common Stock | 1050 | $287.96 | 151,080.0000 | 232,900,000 | 0.70% | 0.00% |
| March 12, 2025 | TARGET CORP | $TGT | BOUDREAUX GAIL | Director | A | Common Stock | 2946 | $0.00 | 9,067.0000 | 461,800,000 | 48.13% | 0.00% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 10620 | $0.00 | 126,993.0000 | 232,900,000 | 9.13% | 0.00% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 15587 | $0.00 | 142,580.0000 | 232,900,000 | 12.27% | 0.01% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 40429 | $0.00 | 40,429.0000 | 232,900,000 | 9999.99% | 0.02% |
| March 3, 2025 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | F | Common Stock | 10396 | $395.50 | 116,373.0000 | 232,900,000 | 8.20% | 0.00% |
| July 22, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | S | Common Stock | 6621 | $501.40 | 132,269.0000 | 237,400,000 | 4.77% | 0.00% |
| July 22, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | S | Common Stock | 2250 | $502.23 | 130,019.0000 | 237,400,000 | 1.70% | 0.00% |
| July 22, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | S | Common Stock | 1000 | $503.67 | 129,019.0000 | 237,400,000 | 0.77% | 0.00% |
| July 22, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | S | Common Stock | 2250 | $504.27 | 126,769.0000 | 237,400,000 | 1.74% | 0.00% |
| July 22, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | S | Common Stock | 20779 | $500.36 | 138,890.0000 | 237,400,000 | 13.01% | 0.01% |
| July 22, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | S | Common Stock | 1100 | $498.50 | 159,669.0000 | 237,400,000 | 0.68% | 0.00% |
| March 13, 2024 | TARGET CORP | $TGT | BOUDREAUX GAIL | Director | A | Common Stock | 1873 | $0.00 | 5,918.0000 | 462,800,000 | 46.30% | 0.00% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | F | Common Stock | 19256 | $499.11 | 117,837.0000 | 237,400,000 | 14.05% | 0.01% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 32480 | $0.00 | 32,480.0000 | 237,400,000 | 9999.99% | 0.01% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 34517 | $0.00 | 160,769.0000 | 237,400,000 | 27.34% | 0.01% |
| March 1, 2024 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 8415 | $0.00 | 126,252.0000 | 237,400,000 | 7.14% | 0.00% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | F | Common Stock | 2471 | $469.03 | 109,240.0000 | 242,800,000 | 2.21% | 0.00% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 35875 | $0.00 | 153,537.0000 | 242,800,000 | 30.49% | 0.01% |
| March 2, 2023 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | F | Common Stock | 17614 | $468.78 | 135,923.0000 | 242,800,000 | 11.47% | 0.01% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Employee Stock Option (Right to Buy) | 32380 | $0.00 | 32,380.0000 | 242,800,000 | 9999.99% | 0.01% |
| March 1, 2023 | Elevance Health, Inc. | $ELV | BOUDREAUX GAIL | President and CEO | A | Common Stock | 8422 | $0.00 | 117,662.0000 | 242,800,000 | 7.71% | 0.00% |